---
figid: PMC6512135__JAH3-8-e010961-g007
figlink: /pmc/articles/PMC6512135/figure/jah34084-fig-0007/
number: Figure 7
caption: Illustration of proposed effects of the phosphoinositide 3‐kinase (PI3K)
  pathway inhibition on the heart in the setting of anthracycline cancer therapy.
  PI3K pathway inhibition, a central pathway downstream of receptor tyrosine kinases
  (RTKs), such as HER2 (Human Epidermal Growth Factor Receptor 2), promotes biventricular
  remodeling with reduced left ventricular (LV) mass and right ventricular (RV) dilation
  and reduced ejection fraction (EF) in the setting of chemotherapy involving wasting
  syndrome (cachexia), MAPK (p38 mitogen‐activated protein kinase) activation, and
  oxidation‐reduction stress. LA indicates left atrium; MAPK, mitogen‐activated protein
  kinase; PA, pulmonary artery; RA, right atrium.
pmcid: PMC6512135
papertitle: PI3Kα Pathway Inhibition With Doxorubicin Treatment Results in Distinct
  Biventricular Atrophy and Remodeling With Right Ventricular Dysfunction.
reftext: Brent A. McLean, et al. J Am Heart Assoc. 2019 May 7;8(9):e010961.
pmc_ranked_result_index: '87625'
pathway_score: 0.8762473
filename: JAH3-8-e010961-g007.jpg
figtitle: Illustration of proposed effects of the phosphoinositide 3‐kinase (PI3K)
  pathway inhibition on the heart in the setting of anthracycline cancer therapy
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6512135__JAH3-8-e010961-g007.html
  '@type': Dataset
  description: Illustration of proposed effects of the phosphoinositide 3‐kinase (PI3K)
    pathway inhibition on the heart in the setting of anthracycline cancer therapy.
    PI3K pathway inhibition, a central pathway downstream of receptor tyrosine kinases
    (RTKs), such as HER2 (Human Epidermal Growth Factor Receptor 2), promotes biventricular
    remodeling with reduced left ventricular (LV) mass and right ventricular (RV)
    dilation and reduced ejection fraction (EF) in the setting of chemotherapy involving
    wasting syndrome (cachexia), MAPK (p38 mitogen‐activated protein kinase) activation,
    and oxidation‐reduction stress. LA indicates left atrium; MAPK, mitogen‐activated
    protein kinase; PA, pulmonary artery; RA, right atrium.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK14
  - ERBB2
  - MAPK11
  - MAPK13
  - MAPK1
  - MAPK3
  - MAPK12
  - FBN1
  - PIK3R5
  - MAPK8
  - PIK3CA
  - PIK3R6
  - PIK3CD
  - PIK3R4
  - MAPK10
  - PIK3CB
  - PIK3R3
  - MAPK9
  - PIK3CG
  - anthracyclines
  - cachexia
genes:
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: (HER2,
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: mass
  symbol: MASS
  source: hgnc_alias_symbol
  hgnc_symbol: FBN1
  entrez: '2200'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
chemicals:
- word: anthracyclines
  source: MESH
  identifier: D018943
diseases:
- word: cachexia
  source: MESH
  identifier: D002100
---
